Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.
Acquired by AbbVie in 2025
Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.
Acquired by AbbVie in 2025